deals

Deals (w/e 12/5/25)

Lee McCabe

07 Dec 2025 — 1 min read

Shore Capital Merges Reliant Healthcare & Care Fusion Rx to Launch a National Infusion-Therapy Platform

Shore Capital has merged Reliant Healthcare, a home-infusion and ambulatory-infusion-center provider operating 14 centers (in Louisiana, Texas, and Oklahoma) plus specialty pharmacies, with Care Fusion Rx, a West-Coast specialty infusion pharmacy focused on complex biologics and immunoglobulin therapies. The merged company will aim to build a national footprint, expanding home and ambulatory infusion access, opening new centers, and consolidating underpopulated regional markets. Link

Goldman Sachs Acquires Innovator Capital Management for $2 B

Goldman Sachs announced it will acquire Innovator Capital Management, the U.S.-based defined-outcome ETF specialist that manages about $28 billion across 159 ETFs, in a deal worth approximately $2 billion (cash + equity). The acquisition expands Goldman’s asset-management and ETF platform. A move that straddles public-market asset managers and private markets investors’ interest. Link

Brookfield Buys Fosber in $900 M Industrial Carve-Out

Brookfield has agreed to acquire Fosber, a global manufacturer of corrugated-packaging machinery and related services, in a carve-out valued at roughly $900 million, aiming to leverage Fosber’s global footprint plus its U.S. operations as part of a broader industrial consolidation thesis. Link

News (w/e 1/9/26)

Eir Partners Closes $1 Billion Fund Focused on Healthcare Technology Miami-based Eir Partners closed its third fund at $1 billion, blowing past its $800 million target in just a few months. The raise reinforces a clear LP preference: specialist healthcare investors with repeatable playbooks still get paid attention, even as

Deals (w/e 1/9/26)

Veritas Capital Buys Majority Stake in Global Healthcare ExchangeVeritas Capital is acquiring a majority stake in Global Healthcare Exchange (GHX), the healthcare supply-chain software platform used by hospitals and suppliers across the U.S. GHX sits in the unglamorous but essential plumbing of healthcare, where scale and data matter more

Private equity has quietly entered a new sport: competitive talent hoarding.

Every firm now appears to be stockpiling operators the way children collected Pokémon cards. Operating Partners, Senior Advisors, Venture Partners, EIRs—hand out a title, add them to a slide, declare victory. LPs love the imagery. It signals “capability.” It looks sophisticated. It gives the impression of a tightly coordinated

AI isn’t coming for middle management. It’s already rearranging the job description.

The layer of people whose primary function is aggregating information, writing summaries, building decks, and “managing up” is about to feel the shift first. Not because AI is more insightful than they are, but because it’s cheaper, faster, and doesn’t need three pre-meetings to prepare for the meeting.